Comprehensive Influenza Diagnostic Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034

What Is the Future Outlook for the Influenza Diagnostic Market's Size and Growth Rate?
In recent years, the influenza diagnostic market has experienced substantial growth. The market size is projected to increase from $2.73 billion in 2024 to $2.89 billion in 2025, maintaining a compound annual growth rate (CAGR) of 5.9%. The strong growth observed in the historical period is credited to factors such as the expansion of e-commerce, labor shortages, the increase in automation and productivity, the optimization of supply chains, escalating labor costs, as well as government endorsement of automation and robotics.

The flu diagnosis market is anticipated to experience robust expansion in the coming years. Its growth is projected to reach $4.01 billion by 2029, with a compound annual growth rate (CAGR) of 8.5%. Several factors, such as adaptability and scalability, ecological and sustainability objectives, the urgency to enhance operational effectiveness, and the requirement to cater to contemporary supply chain dynamics are driving this growth. Notable trends throughout this forecast period encompass the incorporation of cutting-edge technologies, robotics in product selection and packaging, autonomous mobile robots, real-time data analysis, artificial intelligence-based decision making, cooperative robots, and advances in robot technology.

What Is Stimulating Growth in the Influenza Diagnostic Market?
The influenza diagnostic market's growth is forecasted to be propelled by rapid diagnostic tests. These tests, utilized as medical procedures or tools, help confirm or reject the presence of a disease or condition. The rising demand for fast and accurate results in healthcare is leading to an uptick in rapid diagnostic tests (RDTs). Rapid influenza diagnostic tests (RIDTs) are particularly beneficial, as they can determine the presence of influenza viral antigens within a brisk 10-15 minutes with a moderate accuracy rate of 50-70%. For example, the Australian Institute of Health and Welfare, a government agency based in Australia specializing in health and disease information, reported in July 2024 that the number of diagnostic imaging services had increased from 28.4 million in 2021-22 to 29.7 million in 2022-23. Consequently, the influenza diagnostic market's growth is being fueled by rapid diagnostic tests.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

Which Key Market Leaders Are Driving Influenza Diagnostic Industry Growth?
Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

What Are the Emerging Trends in the Influenza Diagnostic Industry?
Leading firms in the influenza diagnostic market are pioneering new products like the Lucira COVID-19 & Flu Home Test for quick, simultaneous detection. This single-use home testing kit, which offers results from personal nasal swab samples in around 30 minutes, is one such innovation. Notably, in February 2023, Pfizer Inc., an American pharmaceutical company, gained approval for this Lucira COVID-19 & Flu Home Test. The kit can identify influenza A and B, often referred to as the flu, along with SARS-CoV-2, the virus behind COVID-19.

What Are the Main Segments in the Influenza Diagnostic Market?
The influenza diagnostic market covered in this report is segmented -

1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests
2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

Subsegments:
1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)
2) By Viral Culture: Cell Culture, Egg-based Culture
3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining
4) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay
5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

Which Geographic Area Leads the Influenza Diagnostic Market?
North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Is Covered In The Influenza Diagnostic Global Market Report?

- Market Size Analysis: Analyze the Influenza Diagnostic Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Influenza Diagnostic Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Influenza Diagnostic Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Influenza Diagnostic Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3237

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.